Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Palmer

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2012
Balloon catheter delivery of helper-dependent adenoviral vector results in sustained, therapeutic hFIX expression in rhesus macaquesNicola Brunetti-Pierri, Aimee Liou, Priti Patel, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 27, 2025
Normal urinary oxalate excretion in 4-hydroxy-2-oxo-glutarate aldolase 1 (HOGA1) deficient mice with AGT expression in peroxisomes and not in mitochondriaIolanda Boffa, Rosa Ferriero, Mariarosaria Cancelliere, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2010
Modifications of adenovirus hexon allow for either hepatocyte detargeting or targeting with potential evasion from Kupffer cellsJan-Michael Prill, Sigrid Espenlaub, Ulrike Samen, et al.
European Child & Adolescent Psychiatry|November 22, 2019
Annual variation in attentional response after methylphenidate treatmentMadelon A Vollebregt, J Leon Kenemans, Jan K Buitelaar, et al.
Viruses|January 29, 2010
Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus VaccinesEric A Weaver, Pramod N Nehete, Bharti P Nehete, et al.
Human Gene Therapy|August 15, 2012
Capsid-modified adenoviral vectors for improved muscle-directed gene therapyKilian Guse, Masataka Suzuki, Gautam Sule, et al.
Journal of Attention Disorders|October 5, 2017
A Signature of Attention-Elicited Electrocortical Activity Distinguishes Response From Non-Response to the Non-Stimulant Atomoxetine in Children and Adolescents With ADHDKristi R Griffiths, Barbora G Jurigova, John E Leikauf, et al.
Journal of Virology|February 22, 2008
High-capacity adenovirus vector-mediated anti-glioma gene therapy in the presence of systemic antiadenovirus immunityGwendalyn D King, A K M Ghulam Muhammad, Weidong Xiong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2008
Immunization against the transgene but not the TetON switch reduces expression from gutless adenoviral vectors in the brainWeidong Xiong, Marianela Candolfi, Kurt M Kroeger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 27, 2006
Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cellsMarianela Candolfi, James F Curtin, Wei-Dong Xiong, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2012
Balloon catheter delivery of helper-dependent adenoviral vector results in sustained, therapeutic hFIX expression in rhesus macaquesNicola Brunetti-Pierri, Aimee Liou, Priti Patel, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 27, 2025
Normal urinary oxalate excretion in 4-hydroxy-2-oxo-glutarate aldolase 1 (HOGA1) deficient mice with AGT expression in peroxisomes and not in mitochondriaIolanda Boffa, Rosa Ferriero, Mariarosaria Cancelliere, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2010
Modifications of adenovirus hexon allow for either hepatocyte detargeting or targeting with potential evasion from Kupffer cellsJan-Michael Prill, Sigrid Espenlaub, Ulrike Samen, et al.
European Child & Adolescent Psychiatry|November 22, 2019
Annual variation in attentional response after methylphenidate treatmentMadelon A Vollebregt, J Leon Kenemans, Jan K Buitelaar, et al.
Viruses|January 29, 2010
Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus VaccinesEric A Weaver, Pramod N Nehete, Bharti P Nehete, et al.
Human Gene Therapy|August 15, 2012
Capsid-modified adenoviral vectors for improved muscle-directed gene therapyKilian Guse, Masataka Suzuki, Gautam Sule, et al.
Journal of Attention Disorders|October 5, 2017
A Signature of Attention-Elicited Electrocortical Activity Distinguishes Response From Non-Response to the Non-Stimulant Atomoxetine in Children and Adolescents With ADHDKristi R Griffiths, Barbora G Jurigova, John E Leikauf, et al.
Journal of Virology|February 22, 2008
High-capacity adenovirus vector-mediated anti-glioma gene therapy in the presence of systemic antiadenovirus immunityGwendalyn D King, A K M Ghulam Muhammad, Weidong Xiong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2008
Immunization against the transgene but not the TetON switch reduces expression from gutless adenoviral vectors in the brainWeidong Xiong, Marianela Candolfi, Kurt M Kroeger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 27, 2006
Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cellsMarianela Candolfi, James F Curtin, Wei-Dong Xiong, et al.
Pageof 5